# Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction

> **NCT01422317** · PHASE3 · COMPLETED · sponsor: **Helse Stavanger HF** · enrollment: 300 (actual)

## Conditions studied

- Coronary Disease
- Myocardial Infarction

## Interventions

- **DRUG:** EPA / DHA / Alpha-Tocopherol
- **DRUG:** Corn Oil / Alpha-Tocopherol (4 mg)

## Key facts

- **NCT ID:** NCT01422317
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-09
- **Primary completion:** 1997-12
- **Final completion:** 2002-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422317, "Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01422317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*